Get Premium to unlock powerful stock data
BELLUS Health Inc logo

BELLUS Health Inc

$ 8.25 -0.24 (-2.83%) 10:08 PM EST
P/E:
At Loss
P/B:
3.19
Market Cap:
$ 881.74M
Enterprise V:
$ 648.61M
Volume:
550.65K
Avg Vol (2M):
812.94K
Also Trade In:
Volume:
550.65K
Market Cap $:
881.74M
PE Ratio:
At Loss
Avg Vol (2-Month):
812.94K
Enterprise Value $:
648.61M
PB Ratio:
3.19
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

BELLUS Health Inc
NAICS : 325414 SIC : 3741
275 Armand-Frappier Boulevard, Laval, QC, CAN, H7V 4A7
Description
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Name Current Vs Industry Vs History
Cash-To-Debt 276.89
Equity-to-Asset 0.94
Debt-to-EBITDA -0.01
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 29.87
Distress
Grey
Safe
Beneish M-Score -2.97
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 49.42
9-Day RSI 51.8
14-Day RSI 52.53
6-1 Month Momentum % 37.7
12-1 Month Momentum % 122.16

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.33
Quick Ratio 15.33
Cash Ratio 14.64
Days Sales Outstanding 10554.41

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -34.6

Financials (Next Earnings Date:2022-08-11 Est.)

BLU's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:BLU

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.016
EPS (TTM) ($) -0.83
Beta 0.01
Volatility % 91.14
14-Day RSI 52.53
14-Day ATR ($) 0.604354
20-Day SMA ($) 8.1445
12-1 Month Momentum % 122.16
52-Week Range ($) 2.6 - 9.84
Shares Outstanding (Mil) 106.75

Piotroski F-Score Details

Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BELLUS Health Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More